JOHNSON & JOHNSON (NYSE: JNJ)

View Portfolio
Back to Investopedia
Back to Investopedia




$62.76 0.39 (0.63%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
65.95
52-Week Low Price
46.25
Avg Volume (3 Mo.)
13.00 M
Market Cap
172.83 B
P/E Ratio (TTM)
14.2
Diluted EPS (TTM)
4.92
Shares
2759.10 M
Dividend Rate ($) / (%)
1.96/3.10
92%
8%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 8% - JNJ has underperformed the S&P 500 by 18%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
PFIZER INC (PFE) $17.82 -  $0.02(0.11%)144.93 B
NOVARTIS AG ADS (NVS) $53.26 -  $0.18(0.34%)120.96 B
MERCK & COMPANY; INC. (MRK) $36.65 -  $0.06(0.16%)113.83 B
GLAXOSMITHKLINE PLC (GSK) $38.19 -  $0.07(0.18%)107.74 B
SANOFI-AVENTIS ADS (SNY) $36.32 -  $0.41(1.14%)93.43 B
ABBOTT LABORATORIES (ABT) $53.75 -  $0.40(0.75%)83.48 B
ASTRAZENECA PLC (AZN) $44.10 -  $0.97(2.25%)62.34 B
AMGEN INC (AMGN) $57.53 -  $0.07(0.12%)58.38 B
TEVA PHARMACEUTICAL LTD (TEVA) $57.10 -  $0.18(0.32%)51.77 B
BRISTOL-MYERS SQUIBB CO (BMY) $24.05 -  $0.09(0.38%)47.48 B
As of February 09, 2010 at 11:05 AM ET
STOCK ANALYSIS
Stock Analysis
J&J: The Most Recession-Resistant Stock In The World? (JNJ, KO, PG, JWN, TIF)
This consumer products giant continues to demonstrate why it's top of its class.
Stock Analysis
Procter Hardly A Gamble (PG, JNJ, KMB, CLX)
Basic necessities are a safe play no matter what the economic state.
Stock Analysis
Stock Analysis
Dividend Yields You Won't Believe (BPO, TGT, JNJ, MO)
When they can be obtained as part of an effort to buy quality companies on the cheap, dividends can create enormous...
Stock Analysis
The Best Capital Allocator In Consumer Goods (SMG, CLX, PG, PM, JNJ)
These six stocks were chosen as favorites in the consumer goods field for 2010. Do they live up to the hype?
View All Stock Analysis
JNJ RELATED HEADLINES
arrow
The Profit Principle
Nicholas Kaiser got into Islamic investing by accident, but there's nothing haphazard about his Amana funds.
Forbes.com 2/8/2010
arrow
Pfizer Drags Down Pharma
In spite of year-over-year gains, the drugmaker's Q4 earnings and 2010 forecast fell short of expectations.
Forbes.com 2/3/2010
arrow
Pfizer Miss Leads Pharma Lower
In spite of year-over-year gains, the drugmaker's Q4 earnings and 2010 forecast fell short of expectations.
Forbes.com 2/3/2010
arrow
Johnson and Johnson (JNJ) NewsBite - JNJ Upgraded By EVA Dimensions, LLC
Johnson and Johnson (JNJ) was upgraded today by analysts at EVA Dimensions, LLC and the stock is now at $63.63, up $0.19 (0.3%) on volume of 6,760,409 shares traded. EVA Dimensions, LLC upgraded the stock today to Overweight from Hold. Over the last 52 weeks the stock has ranged from a low of $46.25 in March to a high of $65.95 earlier this month. Johnson and Johnson stock has been showi...
At Market Intelligence Center 1/28/2010
arrow
J&J: The Most Recession-Resistant Stock In The World? (JNJ, KO, PG, JWN, TIF)
This consumer products giant continues to demonstrate why it's top of its class.
at Investopedia Advisor 1/27/2010
arrow
Stocks Rise, Then Fall On Bank Fears
Upbeat consumer figures and earnings lift markets early, but financial shares sink the indexes.
Forbes.com 1/26/2010
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1